Skip to main content
TipRanks
Go Ultimate75% OFF

Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP) Stock Statistics & Valuation Metrics

11 Followers

Total Valuation

Beximco Pharmaceuticals Limited Sponsored GDR RegS has a market cap or net worth of GBX 66.74B. The enterprise value is GBX 229.05M.

Market Cap
GBX 66.74B
Enterprise Value
GBX 229.05M

Share Statistics

Beximco Pharmaceuticals Limited Sponsored GDR RegS has 446,112,100 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
446,112,100
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Beximco Pharmaceuticals Limited Sponsored GDR RegS’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
371.12K
Employee Count
6,000
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, Beximco Pharmaceuticals Limited Sponsored GDR RegS had revenue of ― and earned 2.23B in profits. Earnings per share was ―.

Revenue
―
Gross Profit
7.18B
Operating Income
3.30B
Pretax Income
―
Net Income
2.23B
EBITDA
3.51B
Earnings Per Share (EPS)
―

Dividends & Yields

Beximco Pharmaceuticals Limited Sponsored GDR RegS pays an annual dividend of GBX 3.35, resulting in a dividend yield of 7.52%

Dividend Per Share
GBX 3.35
Dividend Yield
7.52%
Payout Ratio
N/A
Free Cash Flow Yield
―
Earnings Yield
―

Stock Price Statistics

Beta
-0.18
52-Week Price Change
41.98%
50-Day Moving Average
56.79
200-Day Moving Average
47.64
Relative Strength Index (RSI)
51.57
Average Volume (3m)
22.80K

Important Dates

Beximco Pharmaceuticals Limited Sponsored GDR RegS upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 09, 2026
Next Earnings Date
Feb 02, 2027
Ex-Dividend Date
Nov 22, 2024

Balance Sheet

Beximco Pharmaceuticals Limited Sponsored GDR RegS has ― in cash and marketable securities with GBX 8.94B in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
GBX 8.94B
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for Beximco Pharmaceuticals Limited Sponsored GDR RegS is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
3.86%
EPS Growth Forecast
19.11%

Scores

Smart Score
6
AI Score
―